271 related articles for article (PubMed ID: 28894697)
1. The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis.
Valenzuela CA; Quintanilla R; Moore-Carrasco R; Brown NE
Front Oncol; 2017; 7():188. PubMed ID: 28894697
[TBL] [Abstract][Full Text] [Related]
2. SASP-Dependent Interactions between Senescent Cells and Platelets Modulate Migration and Invasion of Cancer Cells.
Valenzuela CA; Quintanilla R; Olate-Briones A; Venturini W; Mancilla D; Cayo A; Moore-Carrasco R; Brown NE
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653055
[TBL] [Abstract][Full Text] [Related]
3. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
Lau L; David G
Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
[No Abstract] [Full Text] [Related]
4. Platelet Activation Is Triggered by Factors Secreted by Senescent Endothelial HMEC-1 Cells In Vitro.
Venturini W; Olate-Briones A; Valenzuela C; Méndez D; Fuentes E; Cayo A; Mancilla D; Segovia R; Brown NE; Moore-Carrasco R
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384773
[TBL] [Abstract][Full Text] [Related]
5. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
6. Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing.
Mongiardi MP; Pellegrini M; Pallini R; Levi A; Falchetti ML
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513872
[TBL] [Abstract][Full Text] [Related]
7. The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging.
Ghosh K; Capell BC
J Invest Dermatol; 2016 Nov; 136(11):2133-2139. PubMed ID: 27543988
[TBL] [Abstract][Full Text] [Related]
8. Identification of Senescent Cells in the Bone Microenvironment.
Farr JN; Fraser DG; Wang H; Jaehn K; Ogrodnik MB; Weivoda MM; Drake MT; Tchkonia T; LeBrasseur NK; Kirkland JL; Bonewald LF; Pignolo RJ; Monroe DG; Khosla S
J Bone Miner Res; 2016 Nov; 31(11):1920-1929. PubMed ID: 27341653
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
[TBL] [Abstract][Full Text] [Related]
10. The Contribution of Physiological and Accelerated Aging to Cancer Progression Through Senescence-Induced Inflammation.
Morales-Valencia J; David G
Front Oncol; 2021; 11():747822. PubMed ID: 34621683
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of phenotype secretor of senescent cells in the development of cancer, aging and the diseases associated with age].
González-Puertos VY; Maciel-Barón LÁ; Barajas-Gómez BA; López-Diazguerrero NE; Königsberg M
Gac Med Mex; 2015; 151(4):491-500. PubMed ID: 26290026
[TBL] [Abstract][Full Text] [Related]
12. "Social Life" of Senescent Cells: What Is SASP and Why Study It?
Borodkina AV; Deryabin PI; Giukova AA; Nikolsky NN
Acta Naturae; 2018; 10(1):4-14. PubMed ID: 29713514
[TBL] [Abstract][Full Text] [Related]
13. Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis.
De Blander H; Morel AP; Senaratne AP; Ouzounova M; Puisieux A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572787
[TBL] [Abstract][Full Text] [Related]
14. Senescent Cells in Cancer Therapy: Friends or Foes?
Wang B; Kohli J; Demaria M
Trends Cancer; 2020 Oct; 6(10):838-857. PubMed ID: 32482536
[TBL] [Abstract][Full Text] [Related]
15. Unmasking senescence: context-dependent effects of SASP in cancer.
Faget DV; Ren Q; Stewart SA
Nat Rev Cancer; 2019 Aug; 19(8):439-453. PubMed ID: 31235879
[TBL] [Abstract][Full Text] [Related]
16. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
[TBL] [Abstract][Full Text] [Related]
17. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
18. Senescence and apoptosis: dueling or complementary cell fates?
Childs BG; Baker DJ; Kirkland JL; Campisi J; van Deursen JM
EMBO Rep; 2014 Nov; 15(11):1139-53. PubMed ID: 25312810
[TBL] [Abstract][Full Text] [Related]
19. c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors.
Flanagan KC; Alspach E; Pazolli E; Parajuli S; Ren Q; Arthur LL; Tapia R; Stewart SA
Oncotarget; 2018 Jan; 9(1):21-36. PubMed ID: 29416593
[TBL] [Abstract][Full Text] [Related]
20. To clear, or not to clear (senescent cells)? That is the question.
Lujambio A
Bioessays; 2016 Jul; 38 Suppl 1():S56-64. PubMed ID: 27417123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
